Sterling C. Johnston, Ph.D.
Affiliations: | 2001 | University of California, Berkeley, Berkeley, CA, United States |
Area:
Public HealthGoogle:
"Sterling Johnston"Cross-listing: Epi Tree
Parents
Sign in to add mentor| Ira B. Tager | grad student | 2001 | UC Berkeley (Epi Tree) | |
| (Methods for identifying and controlling confounding by indication in observational studies.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Chen H, Pan Y, Zong L, et al. (2020) Cerebral small vessel disease or intracranial large vessel atherosclerosis may carry different risk for future strokes. Stroke and Vascular Neurology. 5: 128-137 |
| Meschia JF, Walton RL, Farrugia LP, et al. (2020) Efficacy of Clopidogrel for Prevention of Stroke Based on Allele Status in the POINT Trial. Stroke. 51: 2058-2065 |
| Kamel H, Zhang C, Kleindorfer DO, et al. (2020) Association of Black Race With Early Recurrence After Minor Ischemic Stroke or Transient Ischemic Attack: Secondary Analysis of the POINT Randomized Clinical Trial. Jama Neurology |
| Cucchiara B, Elm J, Easton JD, et al. (2020) Disability After Minor Stroke and Transient Ischemic Attack in the POINT Trial. Stroke. 51: 792-799 |
| Pu Y, Liu X, Wang Y, et al. (2020) Higher Early Recurrence Risk and Potential Benefit of Dual Antiplatelet Therapy for minor stroke with watershed infarction--Subgroup Analysis of CHANCE. European Journal of Neurology |
| Farrant M, Easton JD, Adelman EE, et al. (2019) Assessment of the End Point Adjudication Process on the Results of the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial: A Secondary Analysis. Jama Network Open. 2: e1910769 |
| Pan Y, Elm JJ, Li H, et al. (2019) Outcomes Associated With Clopidogrel-Aspirin Use in Minor Stroke or Transient Ischemic Attack: A Pooled Analysis of Clopidogrel in High-Risk Patients With Acute Non-Disabling Cerebrovascular Events (CHANCE) and Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trials. Jama Neurology |
| Cucchiara B, George DK, Kasner SE, et al. (2019) Disability after minor stroke and TIA: A secondary analysis of the SOCRATES trial. Neurology |
| Johnston SC, Elm JJ, Easton JD, et al. (2019) Time Course for Benefit and Risk of Clopidogrel and Aspirin after Acute Transient Ischemic Attack and Minor Ischemic Stroke: A Secondary Analysis from the POINT Randomized Trial. Circulation |
| Wang Y, Chen W, Lin Y, et al. (2019) Ticagrelor plus aspirin versus clopidogrel plus aspirin for platelet reactivity in patients with minor stroke or transient ischaemic attack: open label, blinded endpoint, randomised controlled phase II trial. Bmj (Clinical Research Ed.). 365: l2211 |